Oaktree Acquisition III Life Sciences EBITDA 2025-2024 | OACC
Oaktree Acquisition III Life Sciences ebitda from 2025 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Oaktree Acquisition III Life Sciences Annual EBITDA (Millions of US $) |
|---|
| Oaktree Acquisition III Life Sciences Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PicoCELA (PCLA) | Japan | $0.173B | 0.00 |
| Aduro Clean Technologies (ADUR) | Canada | $0.156B | 0.00 |
| Range Capital Acquisition (RANG) | United States | $0.140B | 0.00 |
| Tavia Acquisition (TAVI) | $0.139B | 0.00 | |
| CO2 Energy Transition (NOEM) | $0.095B | 0.00 | |
| Leishen Energy Holding (LSE) | China | $0.089B | 0.00 |
| YHN Acquisition I (YHNA) | $0.081B | 0.00 | |
| Youxin Technology (YAAS) | $0.065B | 0.00 | |
| YSX Tech (YSXT) | China | $0.062B | 0.00 |
| New Century Logistics (BVI) (NCEW) | Hong Kong, SAR China | $0.026B | 0.00 |
| Hong Kong Pharma Digital Technology Holdings (HKPD) | $0.019B | 0.00 | |
| Sky Quarry (SKYQ) | $0.016B | 0.00 | |
| Flowco Holdings (FLOC) | $0.000B | 0.00 |